Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02922 | Pages: NA | Charts: NA | Tables: NA |
Plaque disclosing medications are used to make dental plaque visible. These medications consist of sucrose and pigments (blue and red) that are able to penetrate and stain the plaque. Hence, it enables the visibility of the plaque. Plaque disclosing medications are available in the form of tablets and solutions.
Rise in geriatric population and increase in occurrences of dental plaques especially in the developing economies, such as India, China, and Brazil. However, less awareness among individuals impede the market growth. Moreover, many awareness programs launched by the government and nonprofit organizations create lucrative opportunities for key market players.
The global plaque disclosing market is segmented based on product type, age group, and geography. Based on product type, the market is divided into plaque disclosing tablets, plaque disclosing solution, and plaque disclosing swabs. Based on age group, it is classified into children, adults, and geriatric population. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as GC Europe N.V., Boots Company PLC., Oral-B, Procter & Gamble, Nippon Zettoc, Sunstar Americas, TePe, Young Dental, and Periogen is also provided in this report.
Key Benefits
Key Market Segments
Key Market Players